166 related articles for article (PubMed ID: 25295732)
1. REG4 independently predicts better prognosis in non-mucinous colorectal cancer.
Kaprio T; Hagström J; Mustonen H; Koskensalo S; Andersson LC; Haglund C
PLoS One; 2014; 9(10):e109600. PubMed ID: 25295732
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.
Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C
Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Significance and Prognostic Implications of REG4 Immunohistochemical Expression in Colorectal Cancer.
Kang G; Oh I; Pyo J; Kang D; Son B
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577861
[No Abstract] [Full Text] [Related]
4. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
5. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
[TBL] [Abstract][Full Text] [Related]
6. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
7. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
8. Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly.
Zhang CY; Zhang R; Zhang L; Wang ZM; Sun HZ; Cui ZG; Zheng HC
World J Gastroenterol; 2023 Sep; 29(35):5104-5124. PubMed ID: 37744296
[TBL] [Abstract][Full Text] [Related]
9. The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma.
Chen S; Gou WF; Zhao S; Niu ZF; Zhao Y; Takano Y; Zheng HC
BMC Cancer; 2015 Jun; 15():471. PubMed ID: 26077911
[TBL] [Abstract][Full Text] [Related]
10. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
[TBL] [Abstract][Full Text] [Related]
12. The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer.
Buijs JT; van Beijnum R; Anijs RJS; Laghmani EH; Sensuk L; Minderhoud C; Ünlü B; Klok FA; Kuppen PJK; Cannegieter SC; Versteeg HH
J Thromb Thrombolysis; 2024 Mar; 57(3):370-380. PubMed ID: 38066386
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of the REG gene family in colorectal carcinoma.
Zheng HC; Sugawara A; Okamoto H; Takasawa S; Takahashi H; Masuda S; Takano Y
J Histochem Cytochem; 2011 Jan; 59(1):106-15. PubMed ID: 21339177
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of two PODXL antibodies in 840 colorectal cancer patients.
Kaprio T; Hagström J; Fermér C; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():494. PubMed ID: 25004935
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD63 independently predicts poor prognosis in colorectal cancer.
Kaprio T; Hagström J; Andersson LC; Haglund C
Histol Histopathol; 2020 Aug; 35(8):887-892. PubMed ID: 32073129
[TBL] [Abstract][Full Text] [Related]
16. High-tissue FRMD6 expression predicts better outcomes among colorectal cancer patients.
von Koskull A; Hagström J; Haglund C; Kaprio T; Böckelman C
Biomarkers; 2024 May; 29(3):127-133. PubMed ID: 38385211
[TBL] [Abstract][Full Text] [Related]
17. REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
Lehtinen L; Vesterkvist P; Roering P; Korpela T; Hattara L; Kaipio K; Mpindi JP; Hynninen J; Auranen A; Davidson B; Haglund C; Iljin K; Grenman S; Siitari H; Carpen O
PLoS One; 2016; 11(3):e0151590. PubMed ID: 26981633
[TBL] [Abstract][Full Text] [Related]
18. REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
Rafa L; Dessein AF; Devisme L; Buob D; Truant S; Porchet N; Huet G; Buisine MP; Lesuffleur T
Int J Oncol; 2010 Mar; 36(3):689-98. PubMed ID: 20126989
[TBL] [Abstract][Full Text] [Related]
19. Expression of REG4 in ovarian mucinous tumors.
Huang Q; Chen X; Lu W; Lai M; Lu B
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
[TBL] [Abstract][Full Text] [Related]
20. MUC5AC hypomethylation is a predictor of microsatellite instability independently of clinical factors associated with colorectal cancer.
Renaud F; Vincent A; Mariette C; Crépin M; Stechly L; Truant S; Copin MC; Porchet N; Leteurtre E; Van Seuningen I; Buisine MP
Int J Cancer; 2015 Jun; 136(12):2811-21. PubMed ID: 25403854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
